Nearly a year after winning an accelerated approval for its DLL3-targeting small cell lung cancer (SCLC) therapy Imdelltra, ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to ...

Following hot on the heels of Monday’s European Commission EC approval of an indication extension for Johnson & Johnson’s ...

Researchers hypothesized that increased counseling, NRT provision, and screening for SDOH, with referrals to community-based services, would improve tobacco abstinence among current smokers.

On Wednesday morning, April 2, UH announced its partnership with Qure.AI, a global health tech startup, to use its AI ...

An ambulance medic who has dedicated her life to saving others is fighting cancer for the second time on the back of a second ...

Tagrisso is associated with positive outcomes among patients with unresectable stage 3 EGFR-mutant non-small cell lung cancer ...

Lung cancer is a major health concern in India, with smoking being a primary cause. However, passive smoking, air pollution, firewood smoke, and hazar ...

Researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy -- opening a new path for lung ...